We present a case of HBV reactivation in a post-acute long-term patient on low dose
steroid replacement therapy. Low dose steroid replacement therapy is not well described
as a cause HBV reactivation. This case illustrates that long-term facility residents
are at risk of HBV reactivation with low dose steroid replacement therapy.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the American Medical Directors AssociationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
